Reshaping the Pharma Industry

Jami Rubin, partner at Goldman Sachs, discusses the impact of Brexit on the pharmaceutical industry, research and development in the sector and companies she's keeping an eye on. She speaks to Bloomberg's Joe Weisenthal, Matt Miller and Carol Massar on "What'd You Miss?" (Source: Bloomberg)

Full Show: Surveillance (07/27)
34:28 - Bloomberg Surveillance hosted by Tom Keene and Francine Lacqua. Guests include Andrew Bailey, chief executive officer at Financial Conduct Authority, Severin Schwan, chief executive officer at Roche Holding AG, and Richard Clarida, global strategic adviser at Pimco. (Source: Bloomberg)
  • QuickTake: Taming U.S. Prescription Drug Prices
  • Oklahoma AG on Lawsuit Against Opioid Drugmakers
  • Full Show: Bloomberg Technology (05/18)